Copyright: ©Author(s) 2026.
World J Psychiatry. Jun 19, 2026; 16(6): 116288
Published online Jun 19, 2026. doi: 10.5498/wjp.v16.i6.116288
Published online Jun 19, 2026. doi: 10.5498/wjp.v16.i6.116288
Table 1 Representative studies on depression and heart failure: Prevalence, prognosis, and intervention outcomes
| Ref. | Design/population | Main focus | Key findings | Main implication |
| Rutledge et al[1], 2006 | Meta-analysis of HF studies | Prevalence and outcomes | Depression is highly prevalent in HF and associated with poorer clinical outcomes | Depression is a highly relevant comorbidity in HF |
| Jiang et al[15], 2001 | Prospective cohort, CHF patients | Mortality and rehospitalization | Depression is associated with increased mortality and rehospitalization risk | Prognostic relevance of depression |
| Sherwood et al[42], 2007 | Prospective cohort, HF patients | Death or hospitalization | Depression predicts death or hospitalization | Depression is a marker of adverse HF prognosis |
| Sokoreli et al[3], 2016 | Systematic review and meta-analysis | Depression/anxiety and mortality | Depression and anxiety predict higher mortality in HF | Supports routine psychosocial risk assessment |
| Mao et al[19], 2025 | Retrospective cohort, HF patients | Ventricular function, adherence, readmission | Greater depression severity is associated with poorer ventricular function, reduced medication adherence, and higher readmission | Supports integration of depression management into HF care |
| O'Connor et al[30], 2010 | Randomized clinical trial | Sertraline in HF with depression | Sertraline does not significantly improve depressive symptoms compared with placebo, and no clear cardiovascular benefit was demonstrated | Antidepressant therapy does not translate into clear HF-specific clinical benefit |
| Angermann et al[26], 2016 | Randomized clinical trial | Escitalopram in HF with depression | No significant reduction in all-cause mortality or hospitalization, and no significant improvement in depressive symptoms | Challenges the assumption that treating depression improves hard HF endpoints |
| Rollman et al[37], 2021 | Randomized clinical trial | Blended collaborative care | Improved mood and mental health-related quality of life, but not rehospitalization or physical function | Collaborative care benefits patient-centered outcomes more than hard endpoints |
| Freedland et al[28], 2015 | Randomized clinical trial | Cognitive behavioral therapy in HF | Benefits for depression and self-care persist at 1 year | Nonpharmacological intervention may improve self-management |
| Freedland et al[29], 2023 | Randomized clinical trial | Depression treatment and self-care | Benefits on depression/self-care persist, but cardiovascular outcome effects remain limited | Supports continued interest in patient-centered outcomes after depression treatment |
- Citation: Cen KY, Liang XL, Zhang ML. Redefining psychocardiology: Integrating depression management into heart failure care for enhanced long-term recovery and prognosis. World J Psychiatry 2026; 16(6): 116288
- URL: https://www.wjgnet.com/2220-3206/full/v16/i6/116288.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i6.116288